ENT infections have severe consequences such as hearing impairment and emotional stress which however, seems to worse the patient's quality of life. 3 The most of the antibiotics were recommended for respiratory and ENT infections with a supposed viral aetiology, such as rhino-pharyngitis and acute bronchitis. The consequences of the various reviews were in agreement showing that antibiotic prescriptions are made in around 40% of all consultations for rhino-pharyngitis and in 80% of those for acute bronchitis. 4 Antibiotics were prescribed in more than 90% of cases of pharyngitis, irrespective of the age of the patient. The variability in antibiotic prescription is attributable to the infecting organisms and antimicrobial sensitivity that vary from country to country, or even from region to region, but other features also involved comprising physician favourite, local policy, costs and lack of local guidelines. 5 India is one of the country where the problem of resistance is most prominent. In particular, the rates of resistant pneumococci in Indian nations have been disturbing. In India, approximately 100% of the healthy people carries bacteria that are resistant to chloramphenicol, ampicillin, nalidixic acid and trimethoprim. 6 Poor patient compliance or noncompliance with drugs is mainly in clinical practice. It has been found to be accompanying with treatment failure and all its significances, namely, worsening of patients' health, additional hospital admissions, the requirement of extra consultations, the use of additional medications and expansion in direct and indirect expenses of disease management. 7 Despite several years of clinical use of antibiotics, little is known about how these medications should be used optimally in the clinic. An essential and still mainly unanswered question is how antibiotics should be dispensed clinically to decrease resistance progress without compromising efficacy and safety. 8 The International Network for the Rational Use of Drugs (INRUD) was established in 1989 to promote the rational use of drugs in developing countries. Several indicators were developed by INRUD in association with WHO that provided objective indices permit for valuation of drug use. 9 Still, there is a necessity for statistics on both antibiotic use and determinants of use from all the provinces of the world.
It is most essential to investigate and supervise prescribing patterns of medicine usage time to time, the basic drug alteration in recommending design to progress the remedial value and decreases the side effects. Drug usage assessment is a continuing, certified and systemic quality enhancement procedure, which is designed to review the medicines which are recommended to the patients, provide a right response to the clinician/other appropriate groups, develop criteria and principles that define optimum drug usage, encourage suitable drug use through education and council the patients. These types of analyses will assistance for health specialists to recommending design of antibiotic rationally and therefore are extreme needed. Here the present demonstration has been designed to express the usage of antibiotic in ENT department of RAMA Medical College, Hapur, India Based on the study results appropriate interventions at the level of the physician and the Institute can be planned to promote rational use of drugs in our set up.
Hence, the present prospective study was aimed to evaluate drug utilization pattern of antibacterial used in ENT infections in patients of outpatient (OPD) and inpatient (IPD) departments at RAMA Medical College, Harpur, India.
METHODS
This was a prospective and observational study conducted at RAMA Medical College, Harpur. The study was conducted over a period of eight months from January 2019 to August 2019. All in-patients who were presented to the ENT Department of the hospital during the study period were enrolled into study. Patient who met the following criteria were enrolled.
Patient were enrolled those are either gender with age more than 20 years, outpatients and in patients who are treated in ENT department and who are diagnosed as acute and chronic disease.
Exclusion criteria
Exclusion criteria were below the age of 20 years; the patients who were not willing to take antimicrobial agents and those were not able to give consent were excluded; those patients who do not want to participate into the study were also excluded from the study.
Ethical approval
The study was approved by the Institutional Ethical Committee of RAMA Medical College, Harpur
Sources of data
Demographic details of the patient and treatment chart were sources of the study data.
Study procedure
The study was started after obtaining the approval from institutional ethical committee (IEC) of RAMA Medical College, Hapur.
Patients who satisfied the above study criteria were included in the study after taking the informed consent. All the information was recorded in case record form (CRF) which was designed according to WHO criteria. Patient's demographic details, complaints, diagnosis, and prescribed drugs was collected from the Prescription form or Case records of the patient and was documented in a suitably designed data collection form.
Statistical analysis
The data were entered in Microsoft excel and data were analysed by SPSS software version 20.
RESULTS
In this study, a total of 816 prescriptions were analysed. 
Age distribution of patient
In Table 1 , the majority patients were between 21-30 years accountable 26.1% and least age group patients were more than 60 years 5.14%. 
Gender distribution of patient
In Table 2 , the gender ratio of the patients' Female: Male was found to be 1.53:1. Out of the 816 patients, 61.9% (505) of patients were female and remaining 38.1% (311) of patients were male. Test of proportion showed that the female patients were more than the male patients. 
Distribution of region
In Table 3 , patients were predominantly from Rural areas (64.8%) compared to the urban areas at 35.2%.
Educational qualification
In Table 4 , In our study it was found that ENT patients is more prevalent among illiterate group 30.8% and least were graduate 11.1%. In Table 6 , a total number of 816 prescriptions contained antibiotics. β lactams was most commonly prescribed, followed by quinolones and aminoglycosides. Macrolide and nitroimidazoles was least prescribed. Table 7 , the maximum concomitant prescribed drug was aceclofenac and serratiopeptidase and least combination were antacid and antiemetic such as pantoprazole and domperidone. Table 8 , the mostly comorbid disease conditions was diabetes and least comorbid disease tuberculosis.
DISCUSSION
The Drug prescription by the physician reveals important data regarding rational drug usage. In general practice, the therapeutic approach for ENT infections is nearly empirical and the main aim of physicians is to treat as specifically as possible, while covering the most likely pathogens. The present study indicates general prescribing trends of antibiotics in the OPD and IPD of ENT department. A total of 976 prescriptions were analysed and the demographic data showed that the number of female patients suffering from ENT disease was more than the number of male patients. Similar findings were reported in a study conducted by by Harish et al. 10 This higher incidence in females may be due to increased exposure of females to kitchen smoke. 11, 12 Majority of the patients were in age group less than 30 years, indicating that most of ENT diseases are common in young adults and children.
Throat infections were the most common infections (40.19%) followed by ear infection (38.4%), followed by infections of nose (14.4%). This is similar to one such study conducted by Farhan et al showing higher incidence of throat infections (50.8%), followed by ear (31.37%) and least were nose infections (26.47%). 13 In the present study, β lactams antibiotics was the most commonly prescribed, followed by quinolones and aminoglycosides. Macrolide and nitroimidazoles was least prescribed. A similar study reported that β-lactam antibiotics (amoxicillin, amoxicillin-clavulanate, cefdinir, cefpodoxime proxetil and cefuroxime axetil) are all considered appropriate for the initial treatment of acute bacterial rhino sinusitis in children. 14 It is well known that indiscriminate use of broad spectrum antibiotics increases bacterial resistance. 15 So, the use of azithromycin and clarithromycin should be indicated only when their broad coverage is required or when other antibiotic use is prohibited due to allergy, etc.
However, a change in the prescribing patterns from a small spectrum to penicillin to amoxicillin/clavulanate, as indicative in our study, could be due to an increase in antibiotic resistance which encourages physicians to choose a broader and safer option. In our study, β-lactams (cefixime) was most commonly prescribed antibiotic. The reason for prescribing the third generation cephalosporins was the preponderant mixed group of infections. This contradicts the study conducted by Ain et al who conducted their study and documented Amoxicillin as the most common antibiotic prescribed. 16 Apart from antimicrobial agents, NSAIDs, H1 antihistaminic, H2 blocker and steroid were prescribed concomitantly for symptomatic relief. Few patients with non-specific throat complaints received antimicrobial therapy. We observed laryngopharyngeal reflux as the most common cause and these patients were responded very well to the proton pump inhibitors. Good numbers of patients were with nasal decongestion complaints were treated with nasal decongestant (xylometazoline). We see that most of the antibiotics used in patients with Sore throat is an overcautious approach of most of our contemporaries. The reason for higher prescription of PPI's in sore throat was rational which was evaluated by means of indirect laryngoscopy or video laryngoscopy in all patients. Majority of the antibiotics were prescribed on grounds of presumption and clinical experience of the physicians. Polypharmacy is known to cause unnecessary adverse reactions, drug interactions, complications, medication non-adherence and increase cost of therapy. 17 A significant number of patients were suffering from concomitant diseases. The most frequent comorbid condition of the study population was found to be diabetes (11.8%), followed by hypertension (6.66%), hypothyroidism, gastritis and tuberculosis were least patients. In a similar study, Mazzaglia et al have reported liver disease as the most concomitant condition, followed by diabetes mellitus, heart disease, ischemic heart disease, malignant neoplasm in acute URTIs. 18 Huchon et al. have reported that the rate of chronic disease was highest in Italy (52%) and lowest in Spain (38%). 19 Therefore, our study indicates that the percentage of concomitant disease (32.2%) was lower than the percentage found in Italy and Spain, whereas diabetes was reported to be common concomitant condition against liver disease in the above-mentioned literature. Cost of antibiotics could be one of the major contributing factors for noncompliance in a developing country like India.
The major numbers of prescriptions were by their brand names which may be because of drug promotional activities by pharmaceutical industries. Numbers of prescriptions with drugs by generic names were less. 20 Prescribing the antimicrobial agents by brand names may affect some of the features of essential drug concept. The overall health expenditure can be reduced by prescribing the drugs by generic names. However, in spite of all these limitations, our study shows few rational prescribing practices. Prescription of antimicrobials in ear, nose and throat infections were according to standard treatment guideline. Continuous motivation, education and monitoring are needed at different levels to encourage rational use of medicines.
CONCLUSION
Fluoroquinolone and β-lactam were the two most frequently prescribed antimicrobial agents which are included in essential drug list. The use of the generic names was found to be satisfactory, but the average number of drug per prescription was high. This outcome is an important tool to guide hospitals and doctors to develop antibiotic policy that helps to decrease chance of antimicrobial resistance and motivate cost effective utilization of antimicrobial agents.
